市場調査レポート

商品コード

1304407

オキシトシン製剤市場：適応症別、投与経路別、由来別、エンドユーザー別、地域別 - 規模、シェア、展望、機会分析、2023～2030年

Oxytocic Pharmaceuticals Market, By Indication, By Route of Administration, By Source of Origin (Synthetic Oxytocin, and Natural Oxytocin ), By End User, and By Region - Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030

出版日: 2023年06月20日
発行: Coherent Market Insights
ページ情報: 英文 160 Pages
納期: 2～3営業日

カスタマイズ可能

価格

PDF (Single User License)

USD 4,500 651,420円

レポートPDFを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は一度のみ可能です。印刷したもののご利用はPDFのライセンス保持者に限定されます。

PDF (Multi User License)

USD 7,000 1,013,320円

レポートPDFを7名までにてご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は7回まで可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Enterprise User License)

USD 10,000 1,447,600円

レポートPDFを同一企業およびその子会社のすべての方に使用頂けるライセンスです。PDF内のテキスト等のコピーは可能です。PDFの印刷回数に制限はありません。印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=144.76円

全表示
概要
目次

概要

サンプル依頼リストに入れる

オキシトシン製剤は、正常な出産のための陣痛誘発時に子宮収縮を刺激し、産後の出血を抑制するために静脈内や筋肉内に投与されます。オキシトシン製剤の投与は、産後出血の予防と治療の両方に役立ちます。オキシトシンは産後の出血を抑えるためにも使用されます。また、妊娠を終了させるために、他の薬や処置とともに使用されることもあります。オキシトシンは、オキシトシンホルモンと呼ばれる薬物の一群に属します。子宮収縮を刺激することで作用します。オキシトシンは、病院やクリニックで医師や医療プロバイダーによって静脈内または筋肉内に投与される溶液（液体）として提供されています。陣痛を誘発するため、または陣痛を増強するためにオキシトシンを注射する場合は、通常、病院で医師の監督下で静脈内に注射します。米国産科婦人科学会（ACOG）によると、子宮アトニーを予防するために子宮強壮剤の予防投与が推奨されています。さらに、陣痛誘発を利用した出産の増加は、予測期間にわたって世界の強心剤市場の成長を押し上げると予想されています。

市場力学

主な市場プレイヤーは、子宮収縮薬の市場開拓をもたらすために、提携や買収などの成長戦略の採用に注力しており、これが世界のオキシトシン製剤市場の成長に寄与しています。

本調査の主な特徴

本レポートは、世界のオキシトシン医薬市場を詳細に分析し、2022年を基準年とした予測期間（2023-2030年）の市場規模および年間平均成長率（CAGR）を提供します。
また、異なるセグメントにわたる潜在的な収益機会を解明し、この市場に対する魅力的な投資提案のマトリックスについて説明しています。
また市場促進要因、抑制要因、機会、新製品の上市や承認、市場動向、地域別の展望、主要企業が採用する競争戦略などに関する主要考察も提供しています。
世界のオキシトシン製剤市場における主な企業を、企業ハイライト、製品ポートフォリオ、主要ハイライト、財務実績、戦略などのパラメータに基づいてプロファイルしています。
本調査の対象となる主要企業には、Fresenius Kabi AG, Biofutura SpA, Baxter Healthcare Corporation, Pfizer, Inc., Ferring B.V., Novartis AG, Teva Pharmaceuticals Industries Ltd., Abbott Laboratories, AdvaCare Pharma, EVER Pharma.が含まれます。
本レポートからの洞察により、マーケティング担当者や企業の経営陣は、将来の製品発売、タイプアップ、市場拡大、マーケティング戦術に関する情報に基づいた意思決定を行うことができます。
世界のオキシトシン製剤の市場レポートは、投資家、サプライヤー、製品メーカー、流通業者、新規参入者、財務アナリストなど、この業界の様々な利害関係者に対応しています。
利害関係者は、世界のオキシトシン製剤市場を分析する際に使用される様々な戦略マトリックスを通じて、意思決定を容易にすることができます。

北米
米国
カナダ
ラテンアメリカ
ブラジル
メキシコ
アルゼンチン
その他ラテンアメリカ
欧州
ドイツ
英国
フランス
イタリア
スペイン
ロシア
その他欧州
アジア太平洋
中国
インド
日本
オーストラリア
韓国
ASEAN
その他のアジア太平洋諸国
中東
GCC
イスラエル
その他中東
アフリカ
南アフリカ
中央アフリカ
北アフリカ

第10章競合情勢

企業プロファイル
- Fresenius Kabi AG
- Biofutura SpA
- Baxter Healthcare Corporation
- Pfizer Inc.
- Ferring B.V.
- Novartis AG
- Teva Pharmaceutical Industries Ltd.
- Abbott
- AdvaCare Pharma
- EVER Pharma

第11章セクション

参考文献
調査手法

Product Code: CMI3354

Oxytocic drugs are administered intravenously and intramuscularly to stimulate uterine contractions during labor induction for normal child birth and control bleeding after childbirth. Administration of Oxytocic drugs help in both prevention and treatment of postpartum hemorrhage. Oxytocin also is used to reduce bleeding after childbirth. It also may be used along with other medications or procedures to end a pregnancy. Oxytocin is in a class of medications called oxytocic hormones. It works by stimulating uterine contractions. Oxytocin comes as a solution (liquid) to be given intravenously (into a vein) or intramuscularly (into the muscle) by a doctor or healthcare provider in a hospital or clinic. If oxytocin injection is given to induce labor or to increase contractions, it is usually given intravenously with medical supervision in a hospital. According to the American College of Obstetricians and Gynecologists (ACOG) prophylactic administration of uterotonic agents to prevent uterine atony is recommended. Furthermore, increasing childbirth using labor induction is expected to boost growth of the global oxytocic pharmaceuticals market over the forecast period.

Market Dynamics

The key market players are focusing on adoption of growth strategies such as partnership and acquisitions, to bring in the development of uterine contractility drugs which is attributed to the growth of global oxytocic pharmaceutical market. For instance, in February 2022, Tonix Pharmaceuticals Holding Corp., a clinical-stage biopharmaceutical company, announced that it has entered into a sponsored research agreement with Inserm Transfert, the private subsidiary of Inserm, on behalf of Inserm (the French National Institute of Health and Medical Research) and Aix-Marseille Universite to study oxytocin in the genetically engineered mouse model of Prader-Willi syndrome, a rare genetic disorder that causes distinct, but related pathological eating disorders in adults and newborns. In adults, Prader-Willi causes hyperphagia, or pathological over-eating, which leads to obesity and other complications associated with significant mortality. In newborns, Prader-Willi causes a deficiency in suckling, which has been shown to be normalized by oxytocin treatment.

Key features of the study:

This report provides an in-depth analysis of the global oxytocic pharmaceuticals market and provides market size (US$ Million) and Compound Annual Growth Rate (CAGR) for the forecast period (2023-2030), considering 2022 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global oxytocic pharmaceuticals market based on the following parameters-Company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Fresenius Kabi AG, Biofutura SpA, Baxter Healthcare Corporation, Pfizer, Inc., Ferring B.V., Novartis AG, Teva Pharmaceuticals Industries Ltd., Abbott Laboratories, AdvaCare Pharma, and EVER Pharma.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global oxytocic pharmaceuticals market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global oxytocic pharmaceuticals market

Detailed Segmentation:

Global Oxytocic Pharmaceuticals Market, By Indication:
- Abortion Induced Incomplete
- Inevitable Abortion
- Postpartum Hemorrhage
- Labor Induction
- Labor Arrest
Global Oxytocic Pharmaceuticals Market, By Route of Administration:
- Intramuscular
- Intravenous Injection/Infusion
Global Oxytocic Pharmaceuticals Market, By Source of Origin:
- Synthetic Oxytocin
- Natural Oxytocin (Animal Pituitary Extract)
Global Oxytocic Pharmaceuticals Market, By End User:
- Hospitals
- Maternity Clinics
Global Oxytocic Pharmaceuticals Market, By Region:
- North America
  - By Country:
- U.S.
- Canada
- Latin America
  - By Country:
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
  - By Country:
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
  - By Country:
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
  - By Country:
- GCC
- Israel
- Rest of Middle East
- Africa
  - By Country:
- South Africa
- Central Africa
- North Africa
Company Profiles
- Fresenius Kabi AG *
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Biofutura SpA
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Baxter Healthcare Corporation
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Pfizer Inc.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Ferring B.V.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Abbott.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Novartis AG
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Teva Pharmaceutical Industries Ltd.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Abbott
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- AdvaCare Pharma
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- EVER Pharma
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies

"*" marked represents similar segmentation in other categories in the respective section.

1. Research Objective and Assumption

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Indication
- Market Snippet, By Route of Administration
- Market Snippet, By Source of Origin
- Market Snippet, By End User
- Market Snippet, By Region
- Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Recent Product Launches
Epidemiology
Merger, Acquisition, and Collaborations
Regulatory Scenario
Key Developments
PEST Analysis

4. Global Oxytocic Pharmaceuticals Market - COVID-19 Impact Analysis

Economic Impact
COVID-19 Epidemiology
Impact on Supply and Demand

5. Global Oxytocic Pharmaceuticals Market, By Indication, 2018 - 2030 (US$ Mn)

Introduction
- Market Share Analysis, 2023 and 2030(%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
Abortion Induced Incomplete
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
Inevitable Abortion
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
Postpartum Hemorrhage
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
Labor Induction
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
Labor Arrest
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)

6. Global Oxytocic Pharmaceuticals Market, By Route of Administration, 2018 - 2030 (US$ Mn)

Introduction
- Market Share Analysis, 2023 and 2030(%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
Intramuscular
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
Intravenous Injection/Infusion
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)

7. Global Oxytocic Pharmaceuticals Market, By Source of Origin, 2018 - 2030 (US$ Mn)

Introduction
- Market Share Analysis, 2023 and 2030(%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Synthetic Oxytocin
- Introduction
- Market Size, Volume and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Million)
Natural Oxytocin (Animal Pituitary Extract)
- Introduction
- Market Size, Volume and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Million)

8. Global Oxytocic Pharmaceuticals Market, By End User, 2018 - 2030 (US$ Mn)

Introduction
- Market Share Analysis, 2023 and 2030(%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Hospitals
- Introduction
- Market Size, Volume and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Million)
Maternity Clinics
- Introduction
- Market Size, Volume and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Million)

9. Global Oxytocic Pharmaceuticals Market, By Region, 2018 - 2030, (US$ Mn)

Introduction
- Market Share Analysis, By Region, 2023 and 2030(%)
- Y-o-Y Growth Analysis, For Regions, 2018-2030
North America
- Market Size and Forecast, By Indication, 2018 - 2030, (US$ Mn)
- Market Size and Forecast, By Route of Administration, 2018 - 2030, (US$ Mn)
- Market Size and Forecast, By Source of Origin, 2018 - 2030, (US$ Mn)
- Market Size and Forecast, By End User, 2018 - 2030, (US$ Mn)
- Market Size and Forecast, By Country, 2018 - 2030, (US$ Mn)
U.S.
Canada
Latin America
- Market Size and Forecast, By Indication, 2018 - 2030, (US$ Mn)
- Market Size and Forecast, By Route of Administration, 2018 - 2030, (US$ Mn)
- Market Size and Forecast, By Source of Origin, 2018 - 2030, (US$ Mn)
- Market Size and Forecast, By End User, 2018 - 2030, (US$ Mn)
- Market Size and Forecast, By Country, 2018 - 2030, (US$ Mn)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
- Market Size and Forecast, By Indication, 2018 - 2030, (US$ Mn)
- Market Size and Forecast, By Route of Administration, 2018 - 2030, (US$ Mn)
- Market Size and Forecast, By Source of Origin, 2018 - 2030, (US$ Mn)
- Market Size and Forecast, By End User, 2018 - 2030, (US$ Mn)
- Market Size and Forecast, By Country, 2018 - 2030, (US$ Mn)
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
- Market Size and Forecast, By Indication, 2018 - 2030, (US$ Mn)
- Market Size and Forecast, By Route of Administration, 2018 - 2030, (US$ Mn)
- Market Size and Forecast, By Source of Origin, 2018 - 2030, (US$ Mn)
- Market Size and Forecast, By End User, 2018 - 2030, (US$ Mn)
- Market Size and Forecast, By Country, 2018 - 2030, (US$ Mn)
China
India
Japan
Australia
South Korea
ASEAN
Rest of APAC
Middle East
- Market Size and Forecast, By Indication, 2018 - 2030, (US$ Mn)
- Market Size and Forecast, By Route of Administration, 2018 - 2030, (US$ Mn)
- Market Size and Forecast, By Source of Origin, 2018 - 2030, (US$ Mn)
- Market Size and Forecast, By End User, 2018 - 2030, (US$ Mn)
- Market Size and Forecast, By Country, 2018 - 2030, (US$ Mn)
GCC
Israel
Rest of Middle East
Africa
- Market Size and Forecast, By Indication, 2018 - 2030, (US$ Mn)
- Market Size and Forecast, By Route of Administration, 2018 - 2030, (US$ Mn)
- Market Size and Forecast, By Source of Origin, 2018 - 2030, (US$ Mn)
- Market Size and Forecast, By End User, 2018 - 2030, (US$ Mn)
- Market Size and Forecast, By Country, 2018 - 2030, (US$ Mn)
South Africa
Central Africa
North Africa

10. Competitive Landscape

Company Profiles
- Fresenius Kabi AG
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
- Biofutura SpA
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
- Baxter Healthcare Corporation
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
- Pfizer Inc.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
- Ferring B.V.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
- Novartis AG
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies
- Teva Pharmaceutical Industries Ltd.
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies
- Abbott
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies
- AdvaCare Pharma
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies
- EVER Pharma
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies

11. Section

References
Research Methodology
About us and Sales Contact

オキシトシン製剤市場：適応症別、投与経路別、由来別、エンドユーザー別、地域別 - 規模、シェア、展望、機会分析、2023～2030年

Oxytocic Pharmaceuticals Market, By Indication, By Route of Administration, By Source of Origin (Synthetic Oxytocin, and Natural Oxytocin ), By End User, and By Region - Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030

市場力学

本調査の主な特徴

目次

第1章調査目的と前提条件

第2章市場概況

第3章市場力学、規制、動向分析

第4章オキシトシン製剤の世界市場-COVID-19影響分析

第5章オキシトシン製剤の世界市場：適応症別、2018年～2030年

第6章オキシトシン製剤の世界市場：投与経路別、2018年～2030年

第7章オキシトシン製剤の世界市場：由来別、2018年～2030年

第8章オキシトシン製剤の世界市場：エンドユーザー別、2018年～2030年

第9章オキシトシン製剤の世界市場：地域別、2018年～2030年

第10章競合情勢

第11章セクション

Market Dynamics

Key features of the study:

Detailed Segmentation:

Table of Contents

1. Research Objective and Assumption

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Oxytocic Pharmaceuticals Market - COVID-19 Impact Analysis

5. Global Oxytocic Pharmaceuticals Market, By Indication, 2018 - 2030 (US$ Mn)

6. Global Oxytocic Pharmaceuticals Market, By Route of Administration, 2018 - 2030 (US$ Mn)

7. Global Oxytocic Pharmaceuticals Market, By Source of Origin, 2018 - 2030 (US$ Mn)

8. Global Oxytocic Pharmaceuticals Market, By End User, 2018 - 2030 (US$ Mn)

9. Global Oxytocic Pharmaceuticals Market, By Region, 2018 - 2030, (US$ Mn)

10. Competitive Landscape

11. Section

オキシトシン製剤市場：適応症別、投与経路別、由来別、エンドユーザー別、地域別 - 規模、シェア、展望、機会分析、2023～2030年

Oxytocic Pharmaceuticals Market, By Indication, By Route of Administration, By Source of Origin (Synthetic Oxytocin, and Natural Oxytocin ), By End User, and By Region - Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030

市場力学

本調査の主な特徴

目次

第1章 調査目的と前提条件

第2章 市場概況

第3章 市場力学、規制、動向分析

第4章 オキシトシン製剤の世界市場-COVID-19影響分析

第5章 オキシトシン製剤の世界市場：適応症別、2018年～2030年

第6章 オキシトシン製剤の世界市場：投与経路別、2018年～2030年

第7章 オキシトシン製剤の世界市場：由来別、2018年～2030年

第8章 オキシトシン製剤の世界市場：エンドユーザー別、2018年～2030年

第9章 オキシトシン製剤の世界市場：地域別、2018年～2030年

第10章 競合情勢

第11章 セクション

Market Dynamics

Key features of the study:

Detailed Segmentation:

Table of Contents

1. Research Objective and Assumption

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Oxytocic Pharmaceuticals Market - COVID-19 Impact Analysis

5. Global Oxytocic Pharmaceuticals Market, By Indication, 2018 - 2030 (US$ Mn)

6. Global Oxytocic Pharmaceuticals Market, By Route of Administration, 2018 - 2030 (US$ Mn)

7. Global Oxytocic Pharmaceuticals Market, By Source of Origin, 2018 - 2030 (US$ Mn)

8. Global Oxytocic Pharmaceuticals Market, By End User, 2018 - 2030 (US$ Mn)

9. Global Oxytocic Pharmaceuticals Market, By Region, 2018 - 2030, (US$ Mn)

10. Competitive Landscape

11. Section

第1章調査目的と前提条件

第2章市場概況

第3章市場力学、規制、動向分析

第4章オキシトシン製剤の世界市場-COVID-19影響分析

第5章オキシトシン製剤の世界市場：適応症別、2018年～2030年

第6章オキシトシン製剤の世界市場：投与経路別、2018年～2030年

第7章オキシトシン製剤の世界市場：由来別、2018年～2030年

第8章オキシトシン製剤の世界市場：エンドユーザー別、2018年～2030年

第9章オキシトシン製剤の世界市場：地域別、2018年～2030年

第10章競合情勢

第11章セクション